In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Verigen AG

Division of Sanofi
www.verigen.de

Latest From Verigen AG

Joint Resurfacing: Boom or Bust?

One of the hottest topics at the 2007 AAOS was the the trend toward resurfacing rather than completely replacing joints damaged by arthritis and other causes. There are a variety of metallic, synthetic and biologic methods used in hip, knee, shoulder and extremity joint resurfacing, many designed for younger patients who wish to remain active and avoid total joint replacement.
Medical Device Platform Technologies

Orthopedic Soft Tissue Repair

Each year more than 1.6 million patients undergo surgeries for the repair of tendons, ligaments and cartilage in the shoulder, knee and ankles. The lack of efficacy of some of past offerings in soft tissue repair has created a pent-up demand for new treatment tools.
Medical Device Platform Technologies

Ars Arthro: Taking Tissue Engineering one Step at a Time

Tissue engineering is one of the most promising technology opportunities in orthopedics. But for the companies that have pursued it, the biological process has become something of a waiting game.
Medical Device Innovation

Ars Arthro AG

Ars Arthro's technology, called CaReS, is a cartilage regeneration system that uses harvested cartilage cells which are isolated, then immediately imbedded in a collagen matrix, and then incubated to create a replacement product that can be shaped or molded by surgeons for a precise fit to fix cartilage defects.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
    • Biomaterials
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • VTSI
  • Verigen Transplantation Service International AG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Sanofi
  • Senior Management
  • Samuel S Asculai, Pres. & CEO
    Achim Rottshaefer, CFO
    Paul J Donnelly, VP, Sales & Mktg.
    Bruno Giannetti, COO
  • Contact Info
  • Verigen AG
    Phone: (49) 214 876 350
    Hemmelrather Weg 201
    Leverkusen, D-51377
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register